Intravenous clomipramine for treatment-resistant obsessive-compulsive disorder

International Journal of Neuropsychopharmacology

Volumn 19, Issue 2, 2016, Pages

  Karameh, Wael Karameh ^a   Khani, Munir ^b  

^a Abu Dhabi Health Services Co   (United Arab Emirates)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Clomipramine; Intravenous clomipramine; Obsessive compulsive disorder; Treatment resistant OCD

Indexed keywords

ALPRAZOLAM; CLOMIPRAMINE; LORAZEPAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LOW DRUG DOSE; MALE; OBSESSIVE COMPULSIVE DISORDER; OPEN STUDY; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; YALE BROWN OBSESSIVE COMPULSIVE SCALE; ADOLESCENT; CLINICAL TRIAL; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; CLOMIPRAMINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84979202562     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv084     Document Type: Article

References (19)

1. Albert A, Aguglia A, Bramante S, Bogetto F, Maina G (2013) Treatment-resistant obsessive-compulsive disorder (OCD): current knowledge and open questions. Clin Neuropsychiatry 10(1):19-30.
2. Bokor G, Anderson P (2014) Obsessive-compulsive disorder. J Pharm Pract 27(2):116-130.
3. Clomipramine Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 48:730-738.
4. Erzegovesi S, Cavallini M.c, Cavedini P, Diaferia G, Locatelli M, Bellodi L (2001) Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol 21:488-492.
5. Fallon BA, Campeas R, Schneier FR, Hollander E, Feerick J, Hatterer J, Goetz D, Davies S, Liebowitz MR (1992) Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 4:70-75.
6. Fallon BA, Liebowitz MR, Campeas R, Schneier FR, Marshall R, Davies S, Goetz D, Klein DF (1998) Intravenous clomipramine for OCD refractory to oral clomipramine: a controlled study. Arch Gen Psychiatry 55:918-924.
7. Koran LM, Faravelli C, Pallanti S (1994) Intravenous clomipramine for obsessive-compulsive disorder. J Clin Psychopharmacol. 14(3):216-218.
8. Koran LM, Sallee F, Pallanti S (1997) Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. Am J Psych 154:396-401.
9. Koran LM, Pallanti S, Paiva RS, Quercioli L (1998) Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder. Eur Neuropsychopharmacol 8(2):121-126.
10. Koran LM, Aboujaoude E, Ward H, Shapira NA, Sallee FR, Gamel N, Elliott M (2006) Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder. J Clin Psychopharmacol 26:79-83.
11. Koran LM, Simpson HB (2013) Guideline watch (March 2013): practice guideline for the treatment of patients with obsessive-compulsive disorder. APA practice guidelines 1-22. http://psychiatryonline.org/pb/assets/raw/sitewide/practice-guidelines/guidelines/ocd-watch.pdf.
12. Mathew SJ, Coplan JD, Perko KA, Goetz RR, de la Neuz M, Hollander E, Liebowitz MR, Fallon BA (2001) Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder. Depress Anxiety 14(4):199-208.
13. Mundo E, Bareggi SR, Pirola R, Bellodi L (1997) Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable? Biol Psychiatry 45:290-294.
14. Mundo E, Rouillon F, Figuera ML, Stigler M (2001) Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine. Hum Psychopharmacol 16(6):461-468.
15. Philpott R (1976) The assessment of drugs in obsessional states. Br J Clin Pharmacol 3(Supp 1):91-95.
16. Ravindran LN, Jung SM, Ravindran AV (2010) Intravenous antiobsessive agents: a review. J Pshychopharmacol 24(3): 287-296.
17. Stein DJ (2002) Obsessive-compulsive disorder. Lancet 360(9330):397-405.
18. Warneke LB (1984) The use of intravenous chlorimipramine in the treatment of obsessive compulsive disorder. Can J Psychiatry 29(2):135-141.
19. Warneke LB (1989) Intravenous chlorimipramine therapy in obsessive-compulsive disorder. Can J Psychiatry 34:853-859.